Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis

PHASE3CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
Interventions
DRUG

Levotuss

oral taken

Trial Locations (1)

Unknown

Included Seoul national hospital,10sites, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Hyundai Pharm

INDUSTRY